Earlier this month, the European Commission (EC) released the “Communication on the Second Regulatory Review on Nanomaterials” report (the Review), along with a Working Paper on nanomaterial types and uses (the Working Paper). The Review highlighted the potential benefits of new nanomaterials and new uses, including electronics, solar panels, batteries and biomedical applications. Established uses […]

Second-quarter revenues for IBO’s Lab Equipment/Consumables Sales Index improved 0.7%, 2.0% excluding currency, to $4,061 million. Operating profits for the Index rose 4.0% to $737 million. Based on continuing operations, operating margin slipped 30 basis points to 17.9% of sales. For the fiscal third quarter ending August 31, revenue for Gerresheimer Life Science Research grew […]

Stem cell research is steadily moving forward. As the award this month of the Nobel Prize in Medicine to Dr. Shinya Yamanaka, who created the first induced pluripotent stem cells (iPSCs), shows, the ability to create stem cells from somatic cells has changed scientific research. Contributing to the research’s advancement has been rapid progress in […]

US, European and Japanese central banks all implemented new economic stimulus strategies this month. The European Central Bank announced plans to buy unlimited government debt, and the Bank of Japan increased its asset purchase program. On September 13, the US Federal Reserve agreed to purchase $40 billion of mortgage securities each month until the economy […]

In October, Bruker will begin shipping its first LC/MS product line, the EVOQ triple quadrupole LC/MS systems. The line consists of the EVOQ Elite and the EVOQ Qube, both of which feature Bruker’s new Advance UHPLC systems (see IBO 5/31/12). Bruker obtained the Advance technology, which provides separations from 100–50,000 nL/min with no hardware changes […]

The second of IBO’s biannual new laboratory roundup focuses on new academic and environmental labs, along with companies expanding their lab presence in Europe. In addition, the table on page 3 highlights plans for new CRO, pharmaceutical and semiconductor labs. Three major chemical firms have recently announced labs in Europe. Dutch chemical company Royal DSM […]

A trend among major analytical instrument and lab product companies is the expansion into clinical diagnostic markets, both regulated products and, in the US, services based on laboratory developed tests (LDTs). Clinical diagnostics is a fast-growing market, with multiple opportunities due to the use of new research technologies for diagnostics, growth in emerging markets and […]

Second-quarter 2011 IBO Life Science Index sales grew 3.1%, 3.2% excluding currency, to $3,326 million. Operating profit expanded 0.6% to $694 million. Based on continuing operations, operating margin slipped 30 basis points to 18.5% of sales. Fiscal third-quarter revenue for Becton Dickinson’s BD Biosciences division declined 2.7% but grew 0.2% excluding currency to $268.2 million […]